Abstract
Chemotherapy, in specific clinical settings, is an effective modality of cancer chemotherapy. Failure of a chemotherapeutic regimen to induce a response may be due to many different factors. Foremost among these is the inability of the drugs to reach the critical cellular target. In this regard, physiological factors may play a large role in the successful outcome of therapy: absorption, distribution, metabolism, and elimination are key principles in successful cancer chemotherapy. Whether the resistance is intrinsic or acquired, it is necessary to understand the underlying molecular mechanisms in order to devise rational therapeutic approaches aimed at circumventing the resistance. Studies carried out using cultured tumor cell models and other systems have established that a variety of mechanisms can contribute to drug resistance (Bellamy et al., 1994; Woolley and Tew, 1988). The glutathione S-transferases (GSTs) may play an important role in protecting the cell from the toxic effects of a wide variety of electrophilic compounds including herbicides, insecticides, and carcinogens as well as antineoplastic agents (Beckett and Hayes, 1993; Hayes and Wolf, 1988). This chapter will focus on our current understanding of the involvement of these enzymes in drug resistance and as tumor markers. In addition, potential means of manipulating these proteins in order to affect the outcome of cancer chemotherapy will be discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Aceto A, C. D, Angelucci S, Tenaglia R, Zezza A, Caccuri AM, Federici G (1989): Glutathione-related enzyme activities in testis of patients with malignant diseases. Clin Chim Acta 183:83–86
Adams KJ, Carmichael J, Wolf CR (1985): Altered mouse bone marrow glutathione and glutathione transferase levels in response to cytotoxins. Cancer Res 45:1669–1673
Anderson ME, Naganuma A, Meister A (1990): Protection against cisplatin toxicity by administration of glutathione ester. Faseb J 4:3251–3255
Ball CR, Connors TA, Double JA, Ujhazy V, Whisson ME (1966): Comparison of nitrogen-mustard-sensitive and -resistant Yoshida sarcomas. Int J Cancer 1:319–327
Bass NM, Kirsch RE, Tuff SA, Marks I, Saunders SJ (1977): Ligandin heterogeniety: Evidence that the two non-identical subunits are the monomers of two distinct proteins. Biochim Biophys Acta 492:163–175
Batist G, Tulpule A, Sinha BK, Katki AG, Myers CE, Cowan KH (1986): Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J Biol Chem 261:15544–15549
Beckett GJ, Howie AF, Hume R, Matharoo B, Hiley C, Jones P, Strange RC (1990): Human glutathione S-transferases: radioimmunoassay studies on the expression of alpha-, mu- and pi-class isoenzymes in develo** lung and kidney. Biochim Biophys Acta 1036:176–182
Beckett GJ, Hayes JD (1993): Glutathione S-transferases: biomedical applications. Adv Clin Chem 30:281–380
Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW (1993): Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione s-transferase Ml (GSTM 1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 85:1159–1164
Bellamy WT, Dalton WS, Meltzer P, Dorr RT (1989): Role of glutathione and its associated enzymes in multidrug-resistant human myeloma cells. Biochem Pharmacol 38:787–793
Bellamy WT, Dalton WS, Gleason MC, Grogan TM, Trent JM (1991): Development and characterization of a melphalan-resistant human multiple myeloma cell line. Cancer Res 51:995–1002
Bellamy WT, Dalton WS (1994): Multidrug resistance in the laboratory and clinic. Adv Clin Chem 31: In press
Benz CG, Keniry MA, Ford JM, Townsend AJ, Cox FW, Palayoor S, Matlin S, Hait WN, Cowan KH (1990): Biochemical correlates of the antitumor and antimitochondrialproperties of gossypol enantiomers. Mol Pharmacol 37:840–847
Bergelson S, Pinkus R, Daniel V (1994): Induction of AP-1 (Fos/Jun) by chemical agents mediates activation of glutathione S-transferase and quinone reductase gene expression. Oncogene 9:565–571
Berhane K, Mannervik B (1990): Inactivation of the genotoxic aldehyde acrolein by human glutathione transferases of classes alpha, mu, and pi. Mol Pharmacol 37:251–254
Black SM, Beggs JD, Hayes JD, Bartoszek A, Muramatsu M, Sakai M, Wolf CR (1990): Expression of human glutathione S-transferases in Saccharomyces cerevisiae confers resistance to the anticancer drugs adriamycin and chlorambucil. Biochem J 268:309–315
Board PG, Suzuki T, Shaw DC (1988): Human muscle glutathione S-transferase (GST-4) shows close homology to human liver GST-1. Biochim Biophys Acta 953:214–217
Board P, Coggan M, Johnston P, Ross V, Suzuki T, Webb G (1990): Genetic heterogeneity of the human glutathione transferases: a complex of gene families. Pharmacol Ther 48:357–369
Bolton MG, Colvin OM, Hilton J (1991): Specificity of isoenzymes of murine glutathione s-transferase for the conjugation of glutathione with L-phenylalanine mustard. Cancer Res 51:2410–2415
Booth J, Boyland E, Sims P (1961): An enzyme from rat liver catalysing conjugations with glutathione. Biochem. J. 79:516–524
Brockmoller J, Kerb R, Drakoulis N, Nitz M, Roots I (1993): Genotype and phenotype of glutathione s-transferase class mu isoenzymes in lung cancer patients and controls. Cancer Res 53:1004–1011
Buller AL, Clapper ML, Tew KD (1987): Glutathione S-transferases in nitrogen mustard-resistant and -sensitive cell lines. Mol Pharmacol 31:575–578
Burgess JR, Chow NW, Reddy CC, Tu CP (1989): Amino acid substitutions in the human glutathione S-transferases confer different specificities in the prostaglandin endoperoxide conversion pathway. Biochem Biophys Res Commun 158:497–502
Calcutt G, Connors TA (1963): Tumour sulfhydryl levels and sensitivity to the nitrogen mustard merophan. Biochem Pharmacol 12:839–845
Carmichael J, Adams DJ, Ansell J, Wolf CR (1986): Glutathione and glutathione transferase levels in mouse granulocytes following cyclophosphamide administration. Cancer Res 46:735–739
Carmichael J, Forrester LM, Lewis AD, Hayes JD, Hayes PC, Wolf CR (1988): Glutathione S-transferase isoenzymes and glutathione peroxidase activity in normal and tumour samples from human lung. Carcinogenesis 9:1617–1621
Caspary WJ, Lanzo DA, Niziak C (1981): Intermediates in the ferrous oxidase cycle of bleomycin. Biochemistry 20:3868–3875
Chao CC, Huang YT, Ma CM, Chou WY, Chao SL (1991): Overexpression of glutathione s-transferase and elevation of thiol pools in a multidrug-resistant human colon cancer cell line. Mol Pharmacol 41:69–75
Chem HD, Romkes-sparks M, Hu JJ, Persad R, Sibley GA, Smith PJ, Branch RA (1994): Homozygous deleted genotype of glutathione s-transferase Ml increases susceptibility to agressive bladder cancer. Proc Amer Assoc Cancer Res 35:285
Ciaccio PJ, Tew KD, LaCreta FP (1990): The spontaneous and glutathione S-transferase-mediated reaction of chlorambucil with glutathione. Cancer Commun 2:279–285
Clapper, ML, Hoffman S J, Tew KD (1990): Sensitization of human colon tumor xenografts to L-phenylalanine mustard using ethacrynic acid. J Cell Pharmacol 1:71–78
Clapper ML, Hoffinan S J, Tew KD (1991a): Glutathione S-transferases in normal and malignant human colon tissue. Biochim Biophys Acta 1096:209–216
Clapper ML, Seestaller LM, Tew KD (1991b): Induction of glutathione -s-transferase alpha RNA in tumor cells following exposure to chlorambucil. Proc Amer Assoc Cancer Res 32:361
Cole SP, Downes HF, Mirski SE, Clements DJ (1989): Alterations in glutathione and glutathione-related enzymesin a multidrug-resistant small cell lung cancer cell line. Mol Pharmacol 37:192–197
Cowell IG, Dixon KH, Pemble SE, Ketterer B, Taylor JB (1988): The structure of the human glutathione S-transferase pi gene. Biochem J 255:79–83
De Miranda P, Beachman L, Creagh TH, Elion GB (1973): The metabolic fate of the methylnitroimidazole moiety of azathioprine in the rat. J Pharmacol Exp Ther 187:588–601
DeJong JL, Morgenstem R, Jornvall H, DePierre JW, Tu CP (1988): Gene expression of rat and human microsomal glutathione S-transferases. J Biol Chem 263:8430–8436
Di Ilio C, Sacchetta P, Del Boccio G, La Rovere G, Federici G (1985): Glutathione peroxidase, glutathione S-transferase and glutathione reductase activities in normal and neoplastic human breast tissue. Cancer Lett 29:37–42
Dirr H, Reinemer P, Huber R (1994): X-ray crystal structures of cytosolic glutathione S-transferases. Implications for protein architecture, substrate recognition and catalytic function. Eur J Biochem 220:645–61
Doroshow JH, Locker GY, Myers CE (1980): Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin. J Clin Invest 65:128–135
Dulik DM, Fenselau C, Hilton J (1986): Characterization of melphalan-glutathione adducts whose formation is catalyzed by glutathione transferases. Biochem Pharmacol 35:3405–3409
Dulik DM, Fenselau C (1987): Conversion of melphalan to 4-(glutathionyl)phenylalanine. A novel mechanism for conjugation by glutathione-S-transferases. Drug Metab Dispos Biol Fate Chem 15:195–199
Eimoto H, Tsutsumi M, Nakajima A, Yamamoto K, Takashima Y, Murayama H, Konishi Y (1988): Expression of glutathione s-transferase placental form in human lung carcinomas. Carcinogenesis 9:2325–2327
Evans CG, Bodell WJ, Tokuda K, Doane-Setzer P, Smith M (1987): Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-l-nitrosourea and nitrogen mustard. Cancer Res 47:2525–2530
Fahey RC, Sundquist AR (1991): Evolution of glutathione metabolism. Adv Enzymol 64:1–53
Fairchild CR, Moscow JA, O’Brien EE, Cowan KH (1990): Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-pi. Mol Pharmacol 37:801–809
Friling RS, Bensimon A, Tichauer Y, Daniel V (1990): Xenobiotic-inducible expression of murine glutathione S-transferase Ya subunit gene is controlled by an electrophile-responsive element. Proc Natl Acad Sci U S A 87:6258–6262
Friling RS, Bergelson S, Daniel V (1992): Two adjacent AP-1-like binding sites form the electrophile-responsive element of the murine glutathione S-transferase Ya subunit gene. Proc Natl Acad Sci USA 89:668–672
Godwin AK, Meister A, O’Dwyer PJ, Huang CS, Hamilton TC, Anderson ME (1992): High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci USA 89:3070–3074
Green JA, Vistica DT, Young RC, Hamilton TC, Rogan AM, Ozols RF (1984): Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion. Cancer Res 44:5427–5431
Gurtoo HL, Hipkins JH, Sharma CD (1981): Role of glutathione in the metabolism-dependent toxicity and chemotherapy of cyclophosphamide. Cancer Res 4l:3584–359l
Guthenberg C, Akerfeldt K, Mannervik B (1979): Purification of glutathione s-transferase from human placenta. Acta Chem Scand B33:595–596
Habig WH, Pabst M J, Jakoby WB (1974): Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130–7139
Habig WH, Pabst MJ, Jakoby WB (1976): Glutathione S-transferase AA from rat liver. Arch Biochem Biophys 175:710–716
Hall A, Robson CN, Hickson ID, Harris AL, Proctor S J, Cattan AR (1989): Possible role of inhibition of glutathione S-transferase in the partial reversal of chlorambucil resistance by indomethacin in a Chinese hamster ovary cell line. Cancer Res 49:6265–6268
Hao XY, Widersten M, Ridderstrom M, Hellman U, Mannervik B (1994): Covariation of glutathione transferase expression and cytostatic drug resistance in HeLa cells: establishment of class Mu glutathione transferase M3-3 as the dominating isoenzyme. Biochem J 291:59–67
Harrison DJ, Kharbanda R, Bishop D, McLelland LI, Hayes JD (1989): Glutathione S-transferase isoenzymes in human renal carcinoma demonstrated by immunohistochemistry. Carcinogenesis 10:1257–1260
Hayes JD, Strange RC, Percy-Robb IW (1979): Identification of two lithocholic acid-binding proteins: separation of ligandin from glutathione s transferase. Biochem J 181:699–708
Hayes JD, Wolf CR (1988): Role of glutathione transferase in drug resistance. In: Glutathione Conjugation, Sies H, Ketterer B, eds. New York: Academic Press
Hayes JD, Judah DJ, Ellis EM, McLellan LI, Neal GE (1993): Role of glutathione s-transferase and aldehyde reductase in resistance to aflatoxin Bl. In: Structure and Function of Glutathione Transferases, Tew KD, Pickett CB, Mantle TJ, Mannervik B, Hayes JD, eds. Boca Raton: CRC Press
Hida T, Kuwabara M, Ariyoshi Y, Takahashi T, Sugiura T, Hosoda K, Niitsu Y, Ueda R (1994): Serum glutathione S-transferase-pi level as a tumor marker for non-small cell lung cancer: Potential predictive value in chemotherapeuti c response. Cancer 73:1377–1382
Hiley C, Fryer A, Bell J, Hume R, Strange RC (1988): The human glutathione S-transferases. Immunohistochemical studies of the developmental expression of Alpha- and Pi-class isoenzymes in liver. Biochem J 254:255–259
Hiratsuka A, Sebata N, Kawashima K, Okuda H, Ogura K, Watabe T, Satoh K, Hatayama I, Tsuchida S, Ishikawa T, et al (1990): A new class of rat glutathione S-transferase Yrs-Yrs inactivating reactive sulfate esters as metabolites of carcinogenic arylmethanols. J Biol Chem 265:11973–11981
Howie AF, Hayes JD, Beckett GJ (1988): Purification of acidic glutathione S-transferases from human lung, placenta and erythrocyte and the development of a specific radioimmunoassay for their measurement. Clin Chim Acta 177:65–75
Howie AF, Bell D, Hayes PC, Hayes JD, Beckett G J (1990a): Glutathione S-transferase isoenzymes in human bronchoalveolar lavage: a possible early marker for the detection of lung cancer. Carcinogenesis 11:295–300
Howie AF, Forrester LM, Glancey MJ, Schlager JJ, Powis G, Beckett GJ, Hayes JD, Wolf CR (1990b): Glutathione S-transferase and glutathione peroxidase expression in normal and tumour human tissues. Carcinogenesis 11:451–458
Hussey A J, Hayes JD, Beckett G J (1987): The polymorphic expression of neutral glutathione S-transferase in human mononuclear leucocytes as measured by specific radioimmunoassay. Biochem Pharmacol 36:4013–4015
Hussey A J, Hayes JD (1992): Characterization of a human class-Theta glutathione S-transferase with activity towards 1-menaphthy1 sulphate. Biochem J 286:929–935
Igwe O (1986): Biologically active intermediates generated by reduced glutathione conjugation pathway. Biochem Pharmacol 35:2987–2994
Imagawa M, Osada S, Okuda A, Muramatsu M (1991): Silencer binding proteins function on multiple cis-elements in the glutathione transferase P gene. Nucleic Acids Res 19:5–10
Ishikawa M, Takayanagi Y, Sasaki K (1989): Modification of cyclophosphamide-induced urotoxicity by buthionine sulfoximine and disulfiram in mice. Res Commun Chem Pathol Pharmacol 65:265–268
Jakoby WB, Ketterer B, Mannervik B (1984): Glutathione transferases: nomenclature. Biochem Pharmacol 33:2539–2540
Ji X, Johnson WW, Sesay MA, Dickert L, Prasad SM, Ammon HL, Armstrong RN, Gilliland GL (1994): Structure and function of the xenobiotic substrate binding site of a glutathione S-transferase as revealed by X-ray crystallographic analysis of product complexes with the diastereomers of 9-(S-glutathionyl) -10-hydroxy-9,10-dihydrophenanthrene. Biochemistry 33:1043–1052
Johnson WW, Liu S, Ji X, Gilliland GL, Armstrong RN (1993): Tyrosine 115 participates both in chemical and physical steps of the catalytic mechanism of a glutathione s-transferase. J. Biol Chem 268:11508–11511
Kamisaka K, Habig WH, Ketley JN, Arias M, Jakoby WB (1975): Multiple forms of human glutathione S-transferase and their affinity for bilirubin. Eur J Biochem 60:153–161
Kantor R, Giardina S, Bartolazzi A, Townsend A, Myers CE, Cowan KH, Longo DL, Natali P (1991): Monoclonal antibodies to glutathione s-transferas pi-immunohistochemical analysis of human tissues and cancers. Int J Cancer 47:193–201
Ketterer B, Meyer DJ, Taylor JB, Pemble S, Coles B, Fraser G (1990): Glutathione s-transferases and protection against oxidative stress. In: Glutathione S-transferases and drug resistance, Hayes JD, Pickett CB, Mantle TJ, eds. London: Taylor and Francis
Ketterer B (1994): The glutathione transferases: role in protection and susceptibility to cancer. Proc Amer Assoc Cancer Res 35:694–695
Kodate C, Fukushi A, Narita T, Kudo H, Soma Y, Sato K (1986): Human placental form of glutathione S-transferase (GST-pi) as a new immunohistochemical marker for human colonic carcinoma. Jpn J Cancer Res 77:226–229
Koskelo K, Valmet E, Tenhunen R (1981): Purification and characterization of an acid glutathione S-transferase from human lung. Scand J Clin Lab Invest 41:683–689
Kraus P, Gross B (1979): Particle-bound glutathione-S-transferases. Enzyme 24:205–208
Laisney V, Nguyen VC, Gross MS, Frezal J (1984): Human genes for glutathione S-transferases. Hum Genet 68:221–227
Leszczynska A, Pfaff E (1982): Activation by reduced glutathione of methotrexate transport into isolated rat liver cells. Biochem Pharmacol 31:1911–1918
Lewis AD, Hickson I, Robson CN, Harris AL, Hayes JD, Griffiths SA, Manson MM, Hall AE, Moss JE, Wolf CR (1987): Amplification and increased expression of alpha class glutathione s-transferase-encoding genes associated with resistance to nitrogen mustards. Proc Natl Acad Sci USA 85:8511–8515
Li Y, Seyama T, Godwin AK, Winokur TS, Lebovitz RM (1988): MTrasT24, a metallothionein-ras fusion gene, modulates expression in cultured rat liver cells of two genes associated with in vivo liver cancer. Proc Natl Acad Sci USA 85:344–348
Mannervik B, Jensson H (1982): Binary combinations of four protein subunits with different catalytic specificities explain the relationship between six basic glutathione S-transferases in rat liver cytosol. J Biol Chem 257:9909–9912
Mannervik B (1985): The isoenzymes of glutathione transferase. Adv Enzymol Relat Areas Mol Biol 57:357–417
Mannervik B, Awasthi YC, Board PG, Hayes JD, Di IC, Ketterer B, Listowsky I, Morgenstern R, Muramatsu M, Pearson WR, et al (1992): Nomenclature for human glutathione transferases. Biochem J 282:305–306
Mannervik B, Berhane K, Bjornestedt R, Board PG, Jones TA, Kolm RH, Olin B, Sinning I, Sroga GE, Stenberg G, Tardioli S, Widersten M (1993): Structural and functional characterization of the binding sites for glutathione (G-site) and the hydrophobic electrophilic substrate (H-site) in glutathione transferases. In: Structure and Function of Glutathione Transferases, Tew KD, Pickett CB, Mantle TJ, Mannervik B, Hayes JD, eds. Boca Raton: CRC Press
Marcus CJ, Habig WH, Jakoby WB (1978): Glutathione transferase from human erythrocytes. Nonidentity with the enzymes from liver. Arch Biochem Biophys 188:287–293
Meikle I, Hayes JD, Walker SW (1992): Expression of an abundant alpha-class glutathione S-transferase in bovine and human adrenal cortex tissues. J Endocrinol 132:83–92
Meister A (1991) Glutathione deficiency produced by inhibition of its synthesis and its reversal: applications in research and therapy Pharmacol Ther 51:155–194
Meister A (1994): Glutathione, ascorbate, and cellular protection. Cancer Res 54: 1969s–1975s
Meyer DJ, Coles B, Pemble SE, Gilmore KS, Fraser GM, Ketterer B (1991): Theta, a new class of glutathione transferases purified from rat and man. Biochem J 274:409–414
Morgan AS, Ciaccio PJ, Tew KD, Schmidt DE, Kelley MK, Flatgaard JE, Villar HO, Lyttle MH, Kauvar LM (1994): Isozyme specific modulation of glutathione s-transferase in cancer therapy. Proc Amer Assoc Cancer Res 356:376
Morgenstern R, Guthenberg C, Depierre JW (1982): Microsomal glutathione S-transferase. Purification, initial characterization and demonstration that it is not identical to the cytosolic glutathione S-transferases A, B and C. Eur J Biochem 128:243–248
Morgenstem R, DePierre JW (1983): Microsomal glutathione transferase. Purification in unactivated form and further characterization of the activation process, substrate specificity and amino acid composition. Eur J Biochem 134:591–597
Morgenstem R, DePierre JW, Jornvall H (1985): Microsomal glutathione transferase. Primary structure. J Biol Chem 260:13976–13983
Morgenstem R, Wallin H, DePierre JW (1987): Mechanisms of activation of the microsomal glutathione transferase. In: Glutathione S-transferases and Carcinogenesis, Mantle TJ, Pickett CB, Hayes JD, eds. London: Taylor and Francis
Moscow JA, Townsend A J, Cowan KH (1989): Elevation of pi class glutathione S-transferase activity in human breast cancer cells by transfection of the GST pi gene and its effect on sensitivity to toxins. Mol Pharmacol 36:22–28
Nakachi K, Imai K, Hayashi S, Kawajiri K (1993): Polymorphisms of the CTP1A1 and glutathione s-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a japanese population. Cancer Res 53:2994–2999
Nazar-Stewart V, Motulsky A, Eaton DL, White E, Hornung S, Leng Z, Stapelton P, Weiss N (1993): The glutathione s-transferase mu polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res 53:2313–2318
Niitsu Y, Takahashi Y, Saito T, Hirata Y, Arisato N, Maruyama H, Kohgo Y, Listowsky I (1989): Serum glutathione-S-transferase-pi as a tumor marker for gastrointestinal malignancies. Cancer 63:317–323
O’Dwyer PJ, LaCreta F, Nash S, Tinsley PW, Schilder R, Clapper ML, Tew KD, Panting L, Litwin S, Comis RL, et al (1991): Phase I study of thiotepa in combination with the glutathione transferase inhibitor ethacrynic acid. Cancer Res 51:6059–6065
O’Dwyer PJ, Hamilton TC, Young RC, LaCreta FP, Carp N, Tew KD, Padavic K, Comis RL, Ozols RF (1992): Depletion of glutathione in normal and malignant human cells in vivo by buthionine sulfoximine: clinical and biochemical results [see comments]. J Natl Cancer Inst 84:264–267
Ogura K, Nishiyama T, Okada T, Kajital J, Narihata H, Watabe T, Hiratsuka A, Watabe T (1991): Molecular cloning and amino acid sequencing of rat liver class theta glutathione S-transferase Yrs-Yrs inactivating reactive sulfate esters of carcinogenic arylmethanols. Biochem Biophys Res Commun 181:1294–1300
Okuda A, Sakai M, Muramatsu M (1987): The structure of the rat glutathione S-transferase P gene and related pseudogenes. J Biol Chem 262:3858–3863
Ozols RF, Louie KG, Plowman J, Behrens BC, Fine RL, Dykes D, Hamilton TC (1987): Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione. Biochem Pharmacol 36:147–153
Ozols RF, Hamilton TC, Masuda H, Young RC (1988): Manipulation of cellular thiols to influence drug resistance. In: Mechanisms of Drug Resistance in Neoplastic Cells, Woolley PV, Tew KD, eds. New York: Academic Press
Pemble SE, Schroeder KR, Taylor JB, Spencer SR, Meyer DJ, Hallier E, Bolt HM, Ketterer B (1994): Human glutathione transferase theta: cDNA cloning and the demonstration of a null polymorphism by PCR. Proc Amer Assoc Cancer Res 35:123
Pendyala L, Creaven P, Weinstein A, Zdanowicz J, Molnar M (1994): Effect of glutathione depletion on the cytotoxicity of iproplatin and cisplation in a melanoma cell line SK-MEL-2. Proc Amer Assoc Cancer Res 35:434
Peters WH, Kock L, Nagengast FM, Roelofs HM (1990): Immunodetection with a monoclonal antibody of glutathione S-transferase mu in patients with and without carcinomas. Biochem Pharmacol, 39591–39597
Pinkus R, Bergelson S, Daniel V (1993): Phenobarbital induction of AP-1 binding activity mediates activation of glutathione s-transferase and quinone reductase gene expression. Biochem J 290:637–640
Power C, Sinha S, Webber C, Manson MM, Neal GE (1987): Transformation related expression of glutathione-s-transferase P in rat liver cells. Carcinogenesis 8:797–801
Puchalski RB, Fahl WE (1990): Expression of recombinant glutathione S-transferase pi, Ya, or Ybl confers resistance to alkylating agents. Proc Natl Acad Sci USA 87:2443–2447
Raghu G, Pierre-Jerome M, Dordal MS, Simonian P, Bauer KD (1993): P-glycoprotein and alterations in the glutathione/glutathione-peroxidase cycle underlie doxorubicin resistance in HL-60-R, a subclone of the HL-60 human leukemia cell line. Int J Cancer 53:804–811
Ramsdell HS, Eaton DL (1990): Mouse liver glutathione s-transferase isoenzyme activity toward aflatoxin B1–8,9-epoxide and benzo[a]pyrene-7,8–9,10-epoxide. Toxicol Appl Pharmacol 105:216–225
Reinemer P, Dirr HW, Ladenstein R, Schaffer J, Gallay O, Huber R (1991): The three-dimensional structure of class pi glutathione S-transferase in complex with glutathione sulfonate at 2.3 A resolution. Embo J 10:1997–2005
Revis NW, Marusic N (1978): Glutathione peroxidase activity and selenium concentration in the hearts of doxorubicin-treated rabbits. J Mol Cell Cardiol 10:945–951
Riou G, Barrois M, Zhou D (1991): Expression of anionic glutathione s transferase (GST-p) gene in carcinomas of the uterine cervix and in normal cervices. Br J Cancer 63:191–194
Robson CN, Lewis AD, Wolf CR, Hayes JD, Hall A, Proctor SJ, Harris AL, Hickson ID (1987): Reduced levels of drug-induced DNA cross-linking in nitrogen mustard-resistant Chinese hamster ovary cells expressing elevated glutathione S-transferase activity. Cancer Res 47:6022–6027
Rodriguiz C, Commes T, Robert J, Rossi J (1993): Expression of P-glycoprotein and anionic glutathione s-transferase genes in non-Hodgkin’s lymphoma. Leuk Res 17:149–156
Rosenberg MC, Colvin CM, Griffith OW, Bigner SH, Elion GB, Horton JK, Lilley E, Bigner D, Friedman HS (1989): Establishment of a melphalan-resistant rhabdomyosarcoma xenograft with cross-reistance to vincristine and enhanced sensitivity following buthionine sulfoximine-mediated glutathione depletion. Cancer Res 49:6917–6922
Rushmore TH, King RG, Paulson KE, Pickett CB (1990): Regulation of glutathione S-transferase Ya subunit gene expression: identification of a unique xenobiotic-responsive element controlling inducible expression by planar aromatic compounds. Proc Natl Acad Sci USA 87:3826–3830
Rushmore TH, Morton MR, Pickett CB (1991): The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J Biol Chem 266:11632–11639
Sakai M, Okuda A, Muramatsu M (1988): Multiple regulatory elements and phorbol 12-O-tetradecanoate 13-acetate responsiveness of the rat placental glutathione transferase gene. Proc Natl Acad Sci USA 85:9456–9460
Sasano H, Miuazaki S, Shiga K, Goukon Y, Nishihira T, Nagura H (1993): Glutathione s-transferase in human esophageal carcinoma. Anticancer Res 13:363–368
Satoh K, Kitahara A, Soma Y, Inaba Y, Hatayama I, Sato K (1985): Purification, induction, and distribution of placental glutathione transferase: a new marker enzyme for preneoplastic cells in the rat chemical hepatocarcinogenesis. Proc Natl Acad Sci USA 82:3964–3968
Schisselbauer JC, Silber R, Papadopoulos E, Abrams K, LaCreta FP, Tew KD (1990): Characterization of glutathione S-transferase expression in lymphocytes from chronic lymphocytic leukemia patients. Cancer Res 50:3562–3568
Seidegard J, Pero RW (1985): The hereditary transmission of high glutathione transferase activity towards trans-stilbene oxide in human mononuclear leukocytes. Hum Genet 69:66–68
Seidegard J, Pero RW, Miller DG, Beattie EJ (1986): A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis 7:751–753
Seidegard J, Vorachek WR, Pero RW, Pearson WR (1988): Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci U S A 85:7293–7297
Seidegard J, Pero RW, Markowitz MM, Roush G, Miller DG, Beattie EJ (1990): Isoenzyme(s) of glutathione transferase (class Mu) as a marker for the susceptibility to lung cancer: a follow up study. Carcinogenesis 11:33–36
Shea TC, Kelley SL, Henner WD (1988): Identification of an anionic form of glutathione transferase present in many human tumors and human tumor cell lines. Cancer Res 48:527–533
Shiratori Y, Soma Y, Maruyama H, Sato S, Takano A, Sato K (1987): Immunohistochemical detection of the placental form of glutathione S-transferase in dysplastic and neoplastic human uterine cervix lesions. Cancer Res 47:6806–6809
Sinning I, Kleywegt GJ, Cowan SW, Reinemer P, Dirr HW, Huber R, Gilliland GL, Armstrong RN, Ji X, Board PG, et al (1993): Structure determination and refinement of human alpha class glutathione transferase A1-1, and a comparison with the Mu and Pi class enzymes. J Mol Biol 232:192–212
Smith MT, Evans CG, Doane SP, Castro VM, Tahir MK, Mannervik B (1989): Denitrosation of 1,3-bis(2-chloroethyl)-1-nitrosourea by class mu glutathione transferases and its role in cellular resistance in rat brain tumor cells. Cancer Res 49:2621–2625
Strange RC, Faulder CG, Davis BA, Hume R, Brown JA, Cotton W, Hopkinson DA (1984): The human glutathione s-transferases: Studies on the tissue distribution and genetic variation of the GST1, GST2 and GST3 isozymes. Ann Hum Genet 48:11–20
Strange RC, Howie AF, Hume R, Matheroo B, Bell J, Hiley C, Jones P, Beckett G J (1989): Radioimmunoassay studies of the developmental expression of alpha, mu and pi class glutathione s-transferases in the develo** liver. Biochim Biophys Acta 993:186–190
Strange RC, Fryer AA, Hiley C, Bell J, Cosser D, Hume R (1990): Developmental expression of GST in human tissues. In: Glutathion S-transferases and Drug Resistance, Hayes JD, Mantle TJ, Pickett CB, eds. London: Taylor and Francis
Strange RC, Matharoo B, Faulder GC, Jones P, Cotton W, Elder JB, Deakin M (1991): The human glutathione S-transferases: a case-control study of the incidence of the GSTl 0 phenotype in patients with adenocarcinoma. Carcinogenesis 12:25–28
Suzukake K, Petro BJ, Vistica DT (1982): Reduction in glutathione content of L-PAM-resistant L1210 cells confers drug sensitivity. Biochem Pharmacol 31:121–124
Suzuki T, Coggan M, Shaw DC, Board PG (1987): Electrophoretic and immunological analysis of human glutathione S-transferase isozymes. Ann Hum Genet 51:95–106
Talcott RE, Levin VA (1983): Glutathione-dependent denitrosation of N,N’-bis(2-chloroethyl)N-nitrosourea (BCNU): nitrite release catalyzed by mouse liver cytosol in vitro. Drug Metab Dispos Biol Fate Chem 11:175–176
Tateoka N, Tsuchida S, Soma Y, Sato K (1987): Purification and characterization of glutathione S-transferases in human kidney. Clin Chim Acta 166:207–18
Tew KD, Bomber AM, Hoffman S J (1988): Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines. Cancer Res 48:3622–3625
Tew KD, Houghton PJ, Houghton JA (1993): Preclinical and Clinical Modulation of Anticancer Drugs, Boca Raton: CRC Press
Tsuchida S, Sekine Y, Shineha R, Nishihira T, Sato K (1989): Elevation of the placental glutathione S-transferase form (GST-pi) in tumor tissues and the levels in sera of patients with cancer. Cancer Res 49:5225–5229
Tsuchida S, Maki T, Sato K (1990): Purification and characterization of glutathione transferases with an activity toward nitroglycerin from human aorta and heart. Multiplicity of the human class Mu forms. J Biol Chem 265:7150–7157
Tutsumi M, Sugisaki T, Makino T, Miyaga N, Nakatani K, Shiratori T, Takahashi S, Konishi Y (1987): Oncofetal expression of glutathione s-transferase placental form in human stomach carcinomas. Jpn J Cancer Res 78:631–633
Volm M, Mattem J, Samsel B (1992): Relationship of inherent resistance to doxorubicin, proliferative activity and expression of P-glycoprotein 170, and glutathione s-transferase-p in human lung tumors. Cancer 70:764–769
Wang AL, Tew KD (1985): Increased glutathione-S-transferase activity in a cell line with acquired resistance to nitrogen mustards. Cancer Treat Rep 69:677–682
Wang YY, Teicher BA, Shea TC, Holden SA, Rosbe KW, al AA, Henner WD (1989): Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance. Cancer Res 49:6185–6192
Warholm M, Guthenberg C, Mannervik B, von BC, Glaumann H (1980): Identification of a new glutathione S-transferase in human liver. Acta Chem Scand [b] 34:607–21
Warholm M, Guthenberg C, Mannervik B (1983): Molecular and catalytic properties of glutathione transferase mu from human liver: an enzyme efficiently conjugating epoxides. Biochemistry 22:3610–3617
Williams D (1985): S-nitrosation and the reactions of S-nitroso compounds. Chem Soc Rev 14:171–196
Wolf CR, Macpherson JS, Smyth JF (1986): Evidence for the metabolism of mitozantrone by microsomal glutathione transferases and 3-methylcholanthrene-inducible glucuronosyl transferases. Biochem Pharmacol 35:1577–1581
Woolley PV, Tew KD (1988): Mechanisms of Drug Resistance in Neoplastic Cells. San Diego: Academic Press
Zhong S, Howie AF, Ketterer B, Taylor J, Hayes JD, Beckett GJ, Wathen CG, Wolf CR, Spurr NK (1991): Glutathione S-transferase mu locus: use of genoty** and phenoty** assays to assess association with lung cancer susceptibility. Carcinogenesis 12:1533–1537
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Birkhäuser Boston
About this chapter
Cite this chapter
Bellamy, W.T. (1995). The Role of Glutathione S-Transferases in Drug Resistance. In: Kellen, J.A. (eds) Alternative Mechanisms of Multidrug Resistance in Cancer. Birkhäuser Boston. https://doi.org/10.1007/978-1-4615-9852-7_2
Download citation
DOI: https://doi.org/10.1007/978-1-4615-9852-7_2
Publisher Name: Birkhäuser Boston
Print ISBN: 978-1-4615-9854-1
Online ISBN: 978-1-4615-9852-7
eBook Packages: Springer Book Archive